Santé Ventures Fund 5

vc$330MCo-investsLeads rounds

◆ Fund Size

$330M

◆ Check Size

$5.0M→$20.0M

◆ Location

United States

◆ Activity

Statusactively investing

◆ Links

Website ↗

◆ Investment Thesis

Focus on early-stage prospects, breakthrough healthcare innovation, and understanding of biology to move the needle from a patient perspective.

◆ About Santé Ventures

Santé Ventures is an Austin-based healthcare and life sciences investor focused on early-stage companies in biotech, medtech, and healthtech. The firm emphasizes thematic investing, rigorous scientific diligence, and hands-on company creation, with an interest in companies that address clinical complexity, capital inefficiency, or outdated care delivery models.[1][5]

◆ Sectors

BiotechDrug DiscoveryMedtechDigital HealthDiagnostics

◆ Stages

seedseries-a

◆ Geography Focus

United States

◆ Team

Name	Title	Role	Links
Casey Cunningham	Partner and Chief Scientific Officer	—	in
Eric Epstein	Partner	—	in
Louis Bock	Venture Partner	—	in

◆ Notable Investments

Reprieve CardiovascularGeneos TherapeuticsFarapulseClaret MedicalTVA MedicalEndovascular EngineeringbeHumanGraiciSolu TherapeuticsTen Bay BioReEmerge, Inc.Jaguar LAA, Inc.RapidPulse, Inc.Endovascular Engineering, Inc.Sonire TherapeuticsReimagine CareOutcomesAIRise HealthCareHive

◆ Traits

Leads rounds

Co-invests

◆ FAQ

What does Santé Ventures Fund 5 invest in?

Santé Ventures Fund 5 invests in Biotech, Drug Discovery, Medtech, Digital Health and Diagnostics at the seed and series-a stages.

Which geographies does Santé Ventures Fund 5 focus on?

Santé Ventures Fund 5 focuses on United States, and is headquartered in United States.

What is Santé Ventures Fund 5's typical check size?

Santé Ventures Fund 5 typically writes checks of $5M to $20M.